DGX (STOCKS)
Quest Diagnostics Inc.
$192.910000
+1.400000 (+0.73%)
Prev close: $191.510000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Services to the Health Industry
- CEO
- James E. Davis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $21,189.92M
- Employees
- 56,000
- P/E (TTM)
- 21.90
- P/B (TTM)
- 2.94
- Dividend Yield
- 167.09%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
11
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$2.42 | $2.38 | +0.0361 | +1.51% |
|
Sep 2025 (Q3)
|
$2.60 | $2.53 | +0.0710 | +2.81% |
|
Jun 2025 (Q2)
|
$2.62 | $2.60 | +0.0242 | +0.93% |
|
Mar 2025 (Q1)
|
$2.21 | $2.17 | +0.0369 | +1.70% |
Financial Statements
| Revenues | $11.04B |
| Benefits Costs and Expenses | $9.72B |
| Cost Of Revenue | $7.37B |
| Costs And Expenses | $9.48B |
| Gross Profit | $3.67B |
| Nonoperating Income/Loss | -$238.00M |
| Operating Expenses | $2.11B |
| Selling, General, and Administrative Expenses | $1.97B |
| Other Operating Expenses | $142.00M |
| Operating Income/Loss | $1.56B |
| Income/Loss Before Equity Method Investments | $1.32B |
| Income/Loss From Continuing Operations After Tax | $1.00B |
| Income/Loss From Continuing Operations Before Tax | $1.32B |
| Income/Loss From Equity Method Investments | $42.00M |
| Income Tax Expense/Benefit | $314.00M |
| Income Tax Expense/Benefit, Deferred | $105.00M |
| Interest And Dividend Income, Operating | $13.00M |
| Interest Income/Expense After Provision For Losses | -$264.00M |
| Interest Income/Expense Operating, Net | -$264.00M |
| Net Income/Loss | $1.05B |
| Net Income/Loss Attributable To Noncontrolling Interest | $54.00M |
| Net Income/Loss Attributable To Parent | $992.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $992.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $4.00M |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $8.87 |
| Diluted Earnings Per Share | $8.75 |
| Basic Average Shares | 111,000,000 |
| Diluted Average Shares | 113,000,000 |
| Assets | $16.23B |
| Current Assets | $2.38B |
| Inventory | $189.00M |
| Other Current Assets | $2.19B |
| Noncurrent Assets | $13.85B |
| Fixed Assets | $2.20B |
| Intangible Assets | $1.64B |
| Other Non-current Assets | $10.01B |
| Liabilities | $8.94B |
| Current Liabilities | $2.28B |
| Wages | $526.00M |
| Other Current Liabilities | $1.75B |
| Noncurrent Liabilities | $6.66B |
| Long-term Debt | $5.67B |
| Other Non-current Liabilities | $990.00M |
| Redeemable Noncontrolling Interest | $80.00M |
| Equity | $7.21B |
| Equity Attributable To Noncontrolling Interest | $36.00M |
| Equity Attributable To Parent | $7.17B |
| Temporary Equity | $80.00M |
| Liabilities And Equity | $16.23B |
| Net Cash Flow From Operating Activities | $1.89B |
| Net Cash Flow From Operating Activities, Continuing | $1.89B |
| Net Cash Flow From Investing Activities | -$631.00M |
| Net Cash Flow From Investing Activities, Continuing | -$631.00M |
| Net Cash Flow From Financing Activities | -$1.39B |
| Net Cash Flow From Financing Activities, Continuing | -$1.39B |
| Exchange Gains/Losses | $4.00M |
| Net Cash Flow | -$129.00M |
| Net Cash Flow, Continuing | -$133.00M |
| Comprehensive Income/Loss | $1.11B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $54.00M |
| Comprehensive Income/Loss Attributable To Parent | $1.05B |
| Other Comprehensive Income/Loss | $61.00M |